About

Dr. Daniel Stumpf

Biotechnologist and embedded partner for life science companies navigating rapid organisational change — from regulatory build-out to R&D team development.

Dr. Daniel Stumpf

Why Co-Lab

Life science companies are at an inflection point.

The life science sector is changing faster than most organisations can adapt. Regulatory requirements are tightening, AI is entering laboratories and clinical workflows, and the pressure to scale efficiently has never been greater.

What I observed across years in research and startup R&D: the organisations that navigate change well do not do it alone. They find partners willing to share the work — not partners who stand outside and point at what should be different.

Stumpf Co-Lab exists to offer that kind of partnership to life science companies. Not consultants who arrive with a framework and leave with an invoice. Co-builders who share the risk, stay for the hard parts, and measure success by what your team can do afterwards.

How I work

Three principles that do not bend.

01

Presence over distance

Real transformation does not happen through reports and recommendations. It happens through shared work, shared risk, and shared accountability. That is why I work inside your team, not across a table from it.

02

Rigour without ego

A decade of scientific training means: asking hard questions, demanding evidence, and not accepting 'that's how we've always done it' as an answer. It also means being wrong sometimes, and saying so openly.

03

People before processes

No technology lands well in an organisation that was not prepared for it. The hardest work of transformation is human work. That is where I spend most of my time.

Background

A decade of building things.

2012 – 2016

B.Sc. Biology

Technische Universität Darmstadt

Focus: Microbiology, Biochemistry, Molecular Genetics. First exposure to synthetic biology through the iGEM competition.

2016 – 2017

M.Sc. Technical Biology

TU Darmstadt / DKFZ Heidelberg

Master's thesis at the German Cancer Research Center: non-viral gene therapy, cell line development, and vector optimisation.

2018 – 2022

PhD in Biotechnology

Max Planck Institute, Göttingen

Development of bacteriophytochrome-based near-infrared fluorescent proteins for super-resolution microscopy. Awarded magna cum laude.

2022 – 2023

Postdoctoral Researcher

Max Planck Institute, Göttingen

Continued protein engineering research and managed European collaborations between Germany and France.

2023 – 2026

Senior Scientist & Research Group Leader

Senostic GmbH, Hannover

Built and led an interdisciplinary R&D team for diagnostic innovation in neurodegenerative diseases. Full regulatory build-out to ISO 13485.

2026 –

Founder

Stumpf Co-Lab, Frankfurt

Embedded consulting at the intersection of regulatory biotechnology and organisational transformation for life science companies.

Enough about me. Let me talk about you.

A first conversation is free, direct, and without obligation. If I am not the right fit, I will say so.

Book a Free Call